Anthrax Protective Antigen-directed Antibody [EPC] - N0000192703

Pharmacologic Class Information

Pharmacologic Code N0000192703
Pharmacologic Name Anthrax Protective Antigen-directed Antibody
Pharmacologic Uses
  • monoclonal antibody directed against the protective antigen of Bacillus anthracis
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Anthrax Protective Antigen-directed Antibody

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Anthrax Protective Antigen-directed Antibody [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
69604-204Anthim Non-Proprietary Name: ObiltoxaximabSolutionIntravenousElusys Therapeutics, Inc.ACTIVE
71655-103Raxibacumab Non-Proprietary Name: RaxibacumabInjectionIntravenousEmergent Manufacturing Operations Baltimore LlcACTIVE